⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for 3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: 3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

Official Title: A Randomized, Open, Comparative Multicentre Trial of 3 Years Anastrozole Treatment vs. 3 Years no Treatment in Postmenopausal Patients With Breast Cancer Who Have Completed 5 Years Adjuvant Hormone Therapy.

Study ID: NCT00300508

Interventions

Anastrozole

Study Description

Brief Summary: The study assesses the effect of a further 3 years adjuvant treatment with anastrozole vs. an untreated control group after initial 5 years of adjuvant hormone-therapy.

Detailed Description:

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Research Site, Amstetten, , Austria

Research Site, Bad Ischl, , Austria

Research Site, Baden, , Austria

Research Site, Bregenz, , Austria

Research Site, Bruck an der Mur, , Austria

Research Site, Dornbirn, , Austria

Research Site, Eisenstadt, , Austria

Research Site, Feldbach, , Austria

Research Site, Feldkirch, , Austria

Research Site, Freistadt, , Austria

Research Site, Fuerstenfeld, , Austria

Research Site, Graz, , Austria

Research Site, Guessing, , Austria

Research Site, Hainburg, , Austria

Research Site, Hartberg, , Austria

Research site, Hollabrunn, , Austria

Research Site, Horn, , Austria

Research Site, Innsbruck, , Austria

Research Site, Kirchdorf, , Austria

Research Site, Klagenfurt, , Austria

Research Site, Klosterneuburg, , Austria

Research Site, Krems, , Austria

Research Site, Kufstein, , Austria

Research Site, Leoben, , Austria

Research Site, Linz, , Austria

Research Site, Mistelbach, , Austria

Research Site, Moedling, , Austria

Research Site, Neunkirche, , Austria

Research Site, Oberpullendorf, , Austria

Research Site, Oberwart, , Austria

Research Site, Ried im Innkreis, , Austria

Research Site, Rohrbach, , Austria

Research Site, Rottenmann, , Austria

Research Site, Salzburg, , Austria

Research Site, Sankt Pölten, , Austria

Research Site, Schaerding, , Austria

Research Site, Scheibbs, , Austria

Research Site, Schladming, , Austria

Research Site, Schwarzach, , Austria

Research Site, Spittal an der Drau, , Austria

Research Site, St. Poelten, , Austria

Research Site, St. Veit an der Glan, , Austria

Research Site, Steyr, , Austria

Research Site, Tulln, , Austria

Research Site, Villach, , Austria

Research Site, Voecklabruck, , Austria

Research Site, Waidhofen an der Ybbs, , Austria

Research Site, Wels, , Austria

Research Site, Wiener Neustadt, , Austria

Research Site, Wien, , Austria

Research Site, Wolfsberg, , Austria

Research Site, Zams, , Austria

Contact Details

Name: AstraZeneca Austria Medical Director, MD

Affiliation: AstraZeneca

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: